The SALL4 Gene Duane Retraction Syndrome Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the SALL4 gene, which are associated with Duane Retraction Syndrome (DRS). This condition is a rare, congenital eye movement disorder characterized by the limited ability to move the eye outward toward the ear (abduction) and, in some cases, limited ability to move the eye inward toward the nose (adduction). It can also be associated with other systemic anomalies due to the role of the SALL4 gene in developmental processes.
The test involves collecting a DNA sample from the patient, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any genetic mutations in the SALL4 gene that are indicative of Duane Retraction Syndrome. This genetic testing is crucial for the accurate diagnosis of DRS, enabling healthcare providers to offer appropriate management strategies and genetic counseling for affected individuals and their families.
The cost of the SALL4 Gene Duane Retraction Syndrome Genetic Test at DNA Labs UAE is set at 4400 AED. This price encompasses the full process of genetic analysis, from sample collection to the provision of results, along with professional interpretation by qualified geneticists. By opting for this test, patients gain valuable insights into their genetic makeup, empowering them with information that can aid in the management of the condition and the understanding of its implications for family planning.
The HMG20B gene, also known as the high mobility group 20B, plays a crucial role in the development and function of the nervous system. Dysmorphisms or mutations in the HMG20B gene can lead to various neurological disorders and developmental issues. Understanding these genetic variations is essential for diagnosing related conditions and developing targeted treatments.
DNA Labs UAE offers a specialized genetic test to identify dysmorphisms in the HMG20B gene. This test is particularly valuable for individuals with a family history of neurological disorders or those exhibiting symptoms related to HMG20B gene mutations. Early detection through this test can facilitate timely intervention and management of potential health issues.
The test cost is set at 4400 AED, reflecting the comprehensive analysis and detailed report provided by DNA Labs UAE. The process involves collecting a DNA sample, usually through a simple and non-invasive method such as a saliva swab or blood sample. The sample is then analyzed in the lab to detect any abnormalities in the HMG20B gene.
Upon completion of the test, patients receive a detailed report outlining the findings. This report can be a valuable tool for healthcare providers to devise a personalized treatment plan or recommend further genetic counseling. DNA Labs UAE ensures confidentiality and accuracy in all testing procedures, offering peace of mind and crucial insights into the patient's genetic health.
The TP63 Gene Ectodactyly Ectodermal Dysplasia and Cleft Lip/Palate Syndrome Type 3 (EEC3) Genetic Test is a specialized diagnostic tool used to identify mutations in the TP63 gene, which are known to cause EEC3. This syndrome is a rare genetic disorder characterized by the combination of ectrodactyly (split or lobster-claw hands and feet), ectodermal dysplasia (abnormal development of skin, hair, nails, teeth, or sweat glands), and cleft lip/palate. Identifying mutations in the TP63 gene can confirm a diagnosis of EEC3, which is crucial for guiding treatment and management decisions, as well as for genetic counseling purposes.
The test is conducted at DNA Labs UAE, a state-of-the-art facility known for its advanced genetic testing services. The cost of the test is 4400 AED. This comprehensive testing service not only aids in the accurate diagnosis of EEC3 but also provides families with the necessary information for understanding the condition's inheritance patterns and the risks for future pregnancies. DNA Labs UAE employs cutting-edge technology and follows stringent protocols to ensure the accuracy and reliability of the test results.
The EVC Gene Ellis-van Creveld Syndrome Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the EVC gene, which are associated with Ellis-van Creveld syndrome. This rare genetic disorder is characterized by skeletal dysplasia, polydactyly, congenital heart defects, and other abnormalities. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect specific genetic alterations in the EVC gene, providing essential information for accurate diagnosis, management, and genetic counseling of affected individuals and their families. DNA Labs UAE employs advanced genetic testing technologies to ensure reliable and precise results, supporting healthcare professionals in delivering personalized care to patients with Ellis-van Creveld syndrome.
The EVC2 Gene Ellis-van Creveld Syndrome Genetic Test is a specialized diagnostic examination available at DNA Labs UAE, designed to detect mutations in the EVC2 gene, which are associated with Ellis-van Creveld Syndrome (EVC). EVC is a rare genetic disorder characterized by short stature, polydactyly, nail dysplasia, dental abnormalities, and congenital heart defects. The test plays a crucial role in the early diagnosis and management of the syndrome, allowing for timely intervention and counseling for affected individuals and their families. Priced at 4400 AED, the test involves analyzing the patient's DNA to identify specific genetic alterations in the EVC2 gene, providing a reliable diagnosis of Ellis-van Creveld Syndrome. Conducted at DNA Labs UAE, the test adheres to high standards of accuracy and confidentiality, ensuring patients receive comprehensive support and information regarding their genetic health.
The COL2A1 gene plays a crucial role in the development and maintenance of the skeletal system, particularly in the formation of collagen which is essential for the strength and integrity of cartilage. Mutations in the COL2A1 gene can lead to a rare condition known as Multiple Epiphyseal Dysplasia (MED) with Myopia and Deafness. This genetic disorder is characterized by abnormalities in the growing ends of bones (epiphyses), leading to skeletal deformities, short stature, and joint pain. Additionally, individuals with this condition often experience nearsightedness (myopia) and varying degrees of hearing loss.
To diagnose this condition, a genetic test targeting the COL2A1 gene can be conducted. DNA Labs UAE offers this specific genetic test, allowing for the identification of mutations in the COL2A1 gene that are responsible for the disorder. The test is priced at 4400 AED and involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of genetic abnormalities associated with Multiple Epiphyseal Dysplasia with Myopia and Deafness.
This genetic testing is vital for the accurate diagnosis of the condition, which can aid in the management and treatment of symptoms, and also provide valuable information for family planning. It is recommended for individuals showing symptoms of the disorder or those with a family history of similar conditions.
The FGD1 Gene Faciogenital Dysplasia Genetic Test is a specialized diagnostic tool designed to identify mutations in the FGD1 gene, which are linked to the development of Faciogenital Dysplasia, also known as Aarskog-Scott syndrome. This rare genetic disorder is characterized by facial abnormalities, genital anomalies, and skeletal dysplasia, affecting predominantly males. The test is crucial for early diagnosis and management of the condition, enabling targeted interventions and genetic counseling for affected families.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample, typically through a blood draw or cheek swab. The laboratory utilizes advanced genomic technologies to analyze the FGD1 gene for any mutations that are known to cause the disorder. The results can provide invaluable insights for healthcare providers, helping to tailor treatment plans according to the specific needs of the patient.
The cost of the FGD1 Gene Faciogenital Dysplasia Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis and the detailed report provided by the lab, which includes interpretation of the results and recommendations for follow-up actions. Given the complexity of genetic disorders and the specialized technology required for accurate testing, the cost reflects the value of obtaining precise, personalized information that can significantly impact the patient's quality of life and management of the condition.
The ERCC4 gene, also known as FANCQ, plays a crucial role in DNA repair processes, particularly in the mechanism of nucleotide excision repair and interstrand cross-link repair. Mutations in this gene can lead to a range of disorders, including Fanconi Anemia (FA), a rare genetic condition characterized by bone marrow failure, increased cancer risk, and various congenital abnormalities. The ERCC4 gene Fanconi Anemia Complementation Group Q genetic test is a specialized diagnostic tool designed to identify mutations in the ERCC4 gene that are associated with Fanconi Anemia Group Q.
This test is particularly important for individuals with a family history of Fanconi Anemia or those presenting symptoms suggestive of the disease. Early and accurate diagnosis through this genetic test can facilitate timely interventions, appropriate management strategies, and genetic counseling for affected individuals and their families.
The test is available at DNA Labs UAE, a leading facility in genetic testing and personalized medicine. The cost of the ERCC4 gene Fanconi Anemia Complementation Group Q genetic test is 4400 AED. DNA Labs UAE employs cutting-edge technology and adheres to international standards in genetic testing, ensuring high accuracy and reliability of test results. Individuals seeking this test can expect professional guidance, confidentiality, and support throughout the testing process.
The MYCN Gene Feingold Syndrome Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the MYCN gene, which are associated with Feingold syndrome. Feingold syndrome is a rare genetic disorder characterized by microcephaly (small head size), short stature, digital anomalies (such as missing or underdeveloped fingers or toes), and gastrointestinal atresia, among other symptoms. The test plays a crucial role in the early detection and management of the syndrome, enabling healthcare providers to offer targeted interventions and support to affected individuals and their families.
Performed at the state-of-the-art facilities of DNA Labs UAE, this genetic test involves analyzing the patient's DNA to look for specific mutations in the MYCN gene that are known to cause Feingold syndrome. The process is highly accurate and provides vital information for the diagnosis and understanding of the condition. The test is priced at 4400 AED, reflecting the advanced technology and expertise required to accurately identify the presence of the MYCN gene mutations.
By opting for the MYCN Gene Feingold Syndrome Genetic Test, patients and their families can gain valuable insights into the genetic basis of the condition, paving the way for personalized care plans and interventions. DNA Labs UAE ensures confidentiality, precision, and comprehensive support throughout the testing process, making it a trusted choice for genetic diagnostics in the region.
The DOK7 Gene Fetal Akinesia Deformation Sequence Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the DOK7 gene, which can lead to Fetal Akinesia Deformation Sequence (FADS). FADS is a rare genetic disorder characterized by reduced fetal movement (akinesia), which can result in a range of physical deformities and developmental issues. These can include joint contractures, lung hypoplasia, facial anomalies, and in severe cases, fetal death.
The DOK7 gene plays a crucial role in the development and maintenance of the neuromuscular junction, which is essential for muscle contraction. Mutations in this gene can disrupt normal neuromuscular signaling, leading to the symptoms associated with FADS. The test offered by DNA Labs UAE employs advanced genetic sequencing techniques to analyze the DOK7 gene for known mutations that are linked to this condition.
This test is particularly valuable for expecting parents with a family history of FADS or related neuromuscular disorders, as it can provide critical insights into the health and development of the fetus. Additionally, it can aid healthcare professionals in planning appropriate medical management and support for affected individuals and their families.
The cost of the DOK7 Gene Fetal Akinesia Deformation Sequence Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to accurately identify mutations in the DOK7 gene, offering peace of mind and vital information for affected families.
